Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Marian Wielosz"'
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 28, Iss 4, Pp 264-268 (2015)
The effectiveness of lithium in the treatment of affective disorders is well documented. However, the mechanism of this effect is still unknown. The purpose of this study was to investigate the effect of lithium on serotonergic neurons. The evaluatio
Autor:
Tomasz Mróz, Jarogniew J. Łuszczki, Piotr Tutka, Marian Wielosz, Roman Mądro, Krzysztof Bańka, Krzysztof Tutaj, Grzegorz Buszewicz, Bartłomiej Barczyński
Publikováno v:
European Journal of Pharmacology. 650:550-555
Experimental evidence indicates that bupropion hydrochloride, an antidepressant and a first-line smoking cessation aid, exerts dose-dependently anticonvulsant and convulsant effects. In this study, chronic bupropion pretreatment intraperitoneally (i.
Publikováno v:
Neuroscience Letters. 435:169-173
We describe a novel aspect of action of memantine ex vivo, in the brain cortical slices and in vitro, in mixed glial cultures. The drug potently increased the production of kynurenic acid, an endogenous tryptophan metabolite blocking N-methyl-D-aspar
Publikováno v:
Epilepsy Research. 64:13-22
Bupropion, a unique, non-nicotine smoking cessation aid and an effective antidepressant, is well known to produce seizures following overdosing in humans. However, the experimental background for the usefulness of antiepileptic drugs in the protectio
Autor:
Jerzy W. Lazarewicz, R. Paczek, Apolonia Ziembowicz, Tomasz Kocki, Ewa M. Urbańska, Elzbieta Luchowska, Piotr Luchowski, Waldemar A. Turski, Marian Wielosz
Publikováno v:
Journal of Neuroscience Research. 79:375-382
Increased serum level of homocysteine, a sulfur-containing amino acid, is considered a risk factor in vascular disorders and in dementias. The effect of homocysteine and metabolically related compounds on brain production of kynurenic acid (KYNA), an
Publikováno v:
European Neuropsychopharmacology. 15:85-93
The role of adenosine A1 receptors in the activity of drugs and substances protecting against seizures evoked by mitochondrial toxin, 3-nitropropionic acid (3-NPA) was studied in mice. Non-selective A1/A2 adenosine receptor antagonist, aminophylline
Publikováno v:
European Neuropsychopharmacology. 14:307-318
Experimental studies have indicated that the central histaminergic system plays an important role in the inhibition of seizures through the stimulation of histamine H 1 receptors. H 1 receptor antagonists, including classical antiallergic drugs, occa
Publikováno v:
Journal of Neural Transmission. 109:455-466
Molsidomine (25 mg kg(-1)), a donor of nitric oxide, commonly used in the treatment of coronary artery disease, enhanced the protective activity of valproate against the clonic phase of pentylenetetrazole-induced seizures in mice, significantly reduc
Autor:
Marian Wielosz, Stanisław J. Czuczwar, Zdzisław Kleinrok, Dorota Żółkowska, Małgorzata Młynarczyk, Piotr Tutka
Publikováno v:
European Journal of Pharmacology. 437:47-53
We studied whether N G -nitro- l -arginine (NNA), an inhibitor of nitric oxide (NO) synthase as well as l -arginine and molsidomine, two agents elevating NO, influenced convulsions caused by 4-aminopyridine, a K + channel blocker in mice. NNA, in a d
Publikováno v:
European Journal of Pharmacology. 431:209-214
In this study, we evaluated whether beta-adrenoceptor antagonists may modify the protective efficacy of dizocilpine (MK-801), a NMDA receptor antagonist, and 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine (GYKI 52466), a non-NMDA